Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses
Type I Interferons were first described for their profound antiviral abilities in cell culture and animal models, and later, they were translated into potent antiviral therapeutics. However, as additional studies into the function of Type I Interferons progressed, it was also seen that pathogenic vi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2019/8685312 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832551285490974720 |
|---|---|
| author | Buyuan He James T. Tran David Jesse Sanchez |
| author_facet | Buyuan He James T. Tran David Jesse Sanchez |
| author_sort | Buyuan He |
| collection | DOAJ |
| description | Type I Interferons were first described for their profound antiviral abilities in cell culture and animal models, and later, they were translated into potent antiviral therapeutics. However, as additional studies into the function of Type I Interferons progressed, it was also seen that pathogenic viruses have coevolved to encode potent mechanisms allowing them to evade or suppress the impact of Type I Interferons on their replication. For chronic viral infections, such as HIV and many of the AIDS-associated viruses, including HTLV, HCV, KSHV, and EBV, the clinical efficacy of Type I Interferons is limited by these mechanisms. Here, we review some of the ways that HIV and AIDS-associated viruses thrive in Type I Interferon-rich environments via mechanisms that block the function of this important antiviral cytokine. Overall, a better understanding of these mechanisms creates avenues to better understand the innate immune response to these viruses as well as plan the development of antivirals that would allow the natural antiviral effect of Type I Interferons to manifest during these infections. |
| format | Article |
| id | doaj-art-d33f2d78834c4ad0a18354e293a3f834 |
| institution | Kabale University |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-d33f2d78834c4ad0a18354e293a3f8342025-02-03T06:01:50ZengWileyJournal of Immunology Research2314-88612314-71562019-01-01201910.1155/2019/86853128685312Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated VirusesBuyuan He0James T. Tran1David Jesse Sanchez2Pharmaceutical Sciences Department, College of Pharmacy, Western University of Health Sciences, Pomona 91766, California, USAPharmaceutical Sciences Department, College of Pharmacy, Western University of Health Sciences, Pomona 91766, California, USAPharmaceutical Sciences Department, College of Pharmacy, Western University of Health Sciences, Pomona 91766, California, USAType I Interferons were first described for their profound antiviral abilities in cell culture and animal models, and later, they were translated into potent antiviral therapeutics. However, as additional studies into the function of Type I Interferons progressed, it was also seen that pathogenic viruses have coevolved to encode potent mechanisms allowing them to evade or suppress the impact of Type I Interferons on their replication. For chronic viral infections, such as HIV and many of the AIDS-associated viruses, including HTLV, HCV, KSHV, and EBV, the clinical efficacy of Type I Interferons is limited by these mechanisms. Here, we review some of the ways that HIV and AIDS-associated viruses thrive in Type I Interferon-rich environments via mechanisms that block the function of this important antiviral cytokine. Overall, a better understanding of these mechanisms creates avenues to better understand the innate immune response to these viruses as well as plan the development of antivirals that would allow the natural antiviral effect of Type I Interferons to manifest during these infections.http://dx.doi.org/10.1155/2019/8685312 |
| spellingShingle | Buyuan He James T. Tran David Jesse Sanchez Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses Journal of Immunology Research |
| title | Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses |
| title_full | Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses |
| title_fullStr | Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses |
| title_full_unstemmed | Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses |
| title_short | Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses |
| title_sort | manipulation of type i interferon signaling by hiv and aids associated viruses |
| url | http://dx.doi.org/10.1155/2019/8685312 |
| work_keys_str_mv | AT buyuanhe manipulationoftypeiinterferonsignalingbyhivandaidsassociatedviruses AT jamesttran manipulationoftypeiinterferonsignalingbyhivandaidsassociatedviruses AT davidjessesanchez manipulationoftypeiinterferonsignalingbyhivandaidsassociatedviruses |